ctrl K

Watchlist Price Alert

Biodexa Pharmaceuticals (BDRX)

NASDAQ: BDRX · Real-Time Price · USD

1.30

0.01 (0.78%)

At close: May 14, 2025, 3:59 PM

1.30

-0.38%

After-hours: May 14, 2025, 05:36 PM EDT

Biodexa Pharmaceuticals Income Statement

Financials in GBP. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	381K	699K	578K	343K	674K	1.94M	989K	1.32M
Cost of Revenue	4.07M	5.11M	4.65M	6.07M	7.84M	9.36M	8.33M	7.73M
Gross Profit	-3.69M	-4.41M	-4.08M	-5.72M	-7.17M	-7.42M	-7.34M	-6.41M
Operating Income	-8.01M	-8.93M	-7M	-10.67M	-11.32M	-11.81M	-11.78M	-9.65M
Interest Income	83K	24K	44K	33K	89K	585K	94K	91K
Pretax Income	-7.49M	-8.49M	-6.11M	-23.47M	-10.92M	-12.4M	-12.97M	-8.39M
Net Income	-7.08M	-7.66M	-5.46M	-22.19M	-9.14M	-10.37M	-11.71M	-6.16M
Selling & General & Admin	4.34M	4.54M	2.95M	4.96M	4.16M	4.39M	4.44M	3.25M
Research & Development	4.07M	5.11M	4.65M	16.15M	7.84M	9.36M	9.83M	7.73M
Other Expenses	-4.08M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	4.33M	4.05M	1.99M	17.71M	3.67M	4.39M	5.54M	2.07M
Interest Expense	41K	53K	44K	34K	97K	587K	109K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	6K	323K	n/a	170K	n/a
Cost & Expenses	8.39M	9.16M	6.64M	23.78M	11.51M	13.75M	13.87M	9.8M
Income Tax Expense	-406K	832K	646K	1.28M	1.78M	2.03M	1.26M	2.23M
Shares Outstanding (Basic)	78.00	30.00	25.00	13.00	5.00	n/a	n/a	n/a
Shares Outstanding (Diluted)	78.00	30.00	25.00	13.00	5.00	n/a	n/a	n/a
EPS (Basic)	-89.65K	-247.89K	-216.92K	-1.66M	-1.6M	n/a	n/a	n/a
EPS (Diluted)	-89.65K	-247.89K	-216.92K	-1.66M	-1.6M	n/a	n/a	n/a
EBITDA	-7.16M	-7.39M	-5.66M	-22.22M	-9.54M	-10.7M	-10.61M	-5.3M
EBIT	-7.44M	-8.44M	-6.06M	-23.44M	-10.83M	-11.81M	-12.86M	-8.31M
Depreciation & Amortization	283K	343K	403K	1.22M	1.28M	1.11M	1.17M	4.35M